Comparison of activity of herpes virus inhibitors.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006561:Herpes Simplex / Q000188:drug therapy; D006564:Herpesviridae / Q000187:drug effects*; D007065:Idoxuridine / Q000494:pharmacology / Q000627:therapeutic use; D014271:Trifluridine / Q000494:pharmacology / Q000627:therapeutic use; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D003561:Cytarabine; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine